News

T1D Exchange Officially Opens the 2018 Diabetes Innovation Challenge Call for Applications

Global Challenge Launched to Identify, Present and Award the Next Breakthrough Solutions for Diabetes Care Boston, MA—November 28, 2017—T1D Exchange, a Boston-based nonprofit organization dedicated to accelerating therapies and improving care in type 1 diabetes, opened the Call for Applications for the 2018 Diabetes Innovation Challenge, a global competition to identify, nurture and fast-track innovative scientific [...]

2017-11-27T10:15:09+00:00 November 28th, 2017|News|

T1D Exchange Joins Leading Diabetes Organizations and Issues Consensus Statement

Leading Diabetes Organizations Issue Consensus Statement Defining Health Outcomes beyond HbA1c The Type 1 Diabetes Outcomes Program, organized by JDRF, has identified and defined clinically meaningful T1D outcomes other than the standard measure of HbA1c. A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines [...]

2017-11-22T12:12:38+00:00 November 22nd, 2017|News|

Dr. Alicia H. McAuliffe-Fogarty Named Vice President of Patient Research for T1D Exchange

Proven leader will oversee research program designed to incorporate patient-reported experiences to impact research, clinical care, and outcomes BOSTON, MA, August 15, 2017 – Alicia H. McAuliffe-Fogarty, PhD, CPsychol has been named vice president of patient-centered research for T1D Exchange, a Boston-based nonprofit organization uniting those affected by disease with those dedicated to accelerating [...]

2017-08-14T10:24:58+00:00 August 15th, 2017|News|

T1D Exchange Invests in Breakthrough Startup Admetsys to Improve Diabetes Care during Hospitalization

Effort Aims to Accelerate Development of the Admetsys Automated Insulin Delivery System for Hospitals and Surgical Centers BOSTON, MA, June 6, 2017 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the organization has invested in Admetsys, the first company to develop an artificial pancreas [...]

2017-06-06T09:16:08+00:00 June 6th, 2017|News|

T1D Exchange Adds Strategic Leadership to Board and Team in Response to Organizational Growth

BOSTON, MA, April 11, 2016 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the election of a new Board member and the addition of three executives to its leadership team. These additions demonstrate the organization’s rapid growth as it continues to build strategic initiatives [...]

2017-04-10T13:58:12+00:00 April 11th, 2017|News|

REPLACE BG: A T1D Exchange Study Confirms Continuous Glucose Monitoring (CGM) Alone is as Safe and Effective as CGM with Blood Glucose Monitoring

T1D Exchange recently published the results of a major study that confirms the use of Continuous Glucose Monitoring (CGM) without regular use of confirmatory Blood Glucose Measurements (BGM) is as safe and effective as use of CGM with confirmatory BGM. This multi-center study enrolled 226 adults with type 1 diabetes (T1D). All study participants were [...]

2017-03-31T08:50:31+00:00 March 20th, 2017|News|

T1D Exchange Joins Patient Groups’ Health Care Letter

T1D Exchange is pleased to partner with 72 organizations that advocate on behalf of people with chronic, serious, and life-threatening diseases such as type 1 diabetes (T1D) to educate the incoming administration and Congress on the unique health insurance needs of our community. On December 14, 2016, we sent a letter to President-elect Trump and [...]

2016-12-15T12:08:10+00:00 December 15th, 2016|News|

T1D Exchange and M2D2 Announce the Winners of the First Annual Diabetes Innovation Challenge

Integrated Medical and Enable Biosciences selected as the co-winners of the first open, global competition to accelerate products and solutions to improve the lives of those living with type 1 and type 2 diabetes Boston, MA – October 21, 2016 – T1D Exchange, an organization dedicated to accelerating research and improving outcomes in type 1 diabetes, [...]

2017-03-20T14:44:28+00:00 October 21st, 2016|News|

Transformational Competitors Advance to the Finals of the Inaugural Diabetes Innovation Challenge

Finalists to present innovative advancements in diabetes diagnostics, therapeutics, devices, or solutions that aim to improve patient outcomes for those living with type 1 and type 2 diabetes Boston, MA – October 13, 2016 – T1D Exchange, an organization dedicated to accelerating research and improving outcomes in type 1 diabetes, and M2D2, a joint venture [...]

2017-02-17T13:01:24+00:00 October 13th, 2016|News|